Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019)
Illumina's (ILMN) quarterly Income from Non-Controlling Interests came in at -$3.0 million in Q2 2019, up 66.67% on a YoY basis from -$1.8 million in Q2 2018, and up 66.67% quarter-over-quarter from -$9.0 million in Q1 2019.
Analysis
Illumina (ILMN) Income from Non-Controlling Interests (2015 - 2019) Analysis & Trends
Illumina (ILMN) has reported Income from Non-Controlling Interests for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q2 2019.
- For the quarter ending Q2 2019, Income from Non-Controlling Interests rose 66.67% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2020 stood at -$3.0 million (up 92.86% YoY), and the FY2019 full-year result was -$12.0 million, up 72.73% from the prior year.
- Income from Non-Controlling Interests grew to -$3.0 million in Q2 2019 per ILMN's latest filing, from -$9.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$1.6 million in Q1 2016 and bottomed at -$19.0 million in Q2 2017.
- Historically, Income from Non-Controlling Interests has averaged -$8.5 million across 5 years, with a median of -$9.0 million in 2018.
- The sharpest annual moves came in 2017 and 2019: Income from Non-Controlling Interests plunged 850.0% in 2017, then soared 66.67% in 2019.
- Over 5 years, Income from Non-Controlling Interests stood at -$2.6 million in 2015, then sank by 369.48% to -$12.0 million in 2016, then increased by 8.33% to -$11.0 million in 2017, then fell by 18.18% to -$13.0 million in 2018, then surged by 76.92% to -$3.0 million in 2019.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$3.0 million, -$9.0 million, and -$13.0 million for Q2 2019, Q1 2019, and Q4 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -3.00 Mn |
| Mar 31, 2019 | -9.00 Mn |
| Dec 30, 2018 | -13.00 Mn |
| Sep 30, 2018 | -11.00 Mn |
| Jul 1, 2018 | -9.00 Mn |
| Apr 1, 2018 | -11.00 Mn |
| Dec 31, 2017 | -11.00 Mn |
| Oct 1, 2017 | -11.00 Mn |
| Jul 2, 2017 | -8.00 Mn |
| Apr 2, 2017 | -19.00 Mn |
| Oct 2, 2016 | -12.00 Mn |
| Jul 3, 2016 | -4.00 Mn |
| Apr 3, 2016 | -2.00 Mn |
| Jan 3, 2016 | -1.61 Mn |
| Sep 27, 2015 | -2.56 Mn |